Alkermes plc (ALKS) Misses Q1 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Alkermes plc Reports First Quarter 2017 Financial Results
April 27, 2017 7:00 AM EDTFirst Quarter Revenues Increased 22% Year-Over-Year to $191.8 Million, GAAP Loss per Share of $0.45 and Non-GAAP Loss per Share of $0.18
VIVITROL® Net Sales Grew by 33% Year-Over-Year to $58.5 Million
ARISTADA® Gaining Traction in Growing Long-Acting Antipsychotic Market; Preparing for Launch of Two-Month Dose Following June 5, 2017 PDUFA Date
DUBLIN--(BUSINESS WIRE)-- Alkermes plc (NASDAQ:... More
